未登录

X

Xinrui Yuan

jiangsu university

H指数:16

被引数:1,133

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

pH-responsive chalcone-polyglycidol prodrugs: Self-assembling micelles for synergistic anticancer and antibacterial therapy

pH响应性查尔酮-聚缩水甘油共药物：用于协同抗癌和抗菌治疗的自组装胶束

COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS

IF5.4

2026-09-290

PRE

Ligand-controlled chemoselective nickel-catalyzed cross-electrophile coupling of cyclic anhydrides with alkyl bromides

配体调控的化学选择性镍催化环酸酐与烷基溴化物的交叉电正体偶联

org. chem. front.

IF0

2026-04-220

OA

An inhibitor of UHM splicing factors exerts anti-leukemic activity by altering cell cycle progression and reducing lysosome acidification

UHM剪接因子的抑制剂通过改变细胞周期进程和减少溶酶体酸化来发挥抗白血病活性。

Cellular Signalling

IF3.7

2025-09-060

PRE

STF: A Spherical Transformer for Versatile Cortical Surfaces Applications

STF：一种用于多样化皮质表面应用的球面Transformer

IF4.5

2025-07-140

OAAI

Targeting Poly(U) Binding Splicing Factor 60 (PUF60): A Small-Molecule Inhibitor Shows Anti-Leukemic Activity and Impacts Cell Cycle in Leukemia Models

靶向Poly(U)结合剪接因子60 (PUF60): 一种小分子抑制剂显示出抗白血病活性并影响白血病模型中的细胞周期

IF23.1

2024-11-050

PRE

Astaxanthin biosynthesis for functional food development and space missions

CRITICAL REVIEWS IN BIOTECHNOLOGY

IF7.7

2024-10-204

OA

Studies of Structure-Activity Relationship of 2-(Pyrrolidin-1ylmethyl)-1H-pyrrole-Based ST2 Inhibitors and Their Inhibition of Mast Cells Activation

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2024-10-180

PRE

Development of an Imidazopyridazine-Based MNK1/2 Inhibitor for the Treatment of Lymphoma

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-04-021

PRE

Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2024-03-015

PRE

Hepatic soluble epoxide hydrolase activity regulates cerebral AD metabolism and the pathogenesis of Alzheimer's disease in mice

IF15

2023-09-0125

OAAI

Profiling the Binding Activities of Peptides and Inhibitors to the U2 Auxiliary Factor Homology Motif (UHM) Domains (vol 14, pg 450, 2023)

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2023-04-140

OA

Profiling the Binding Activities of Peptides and Inhibitors to the U2 Auxiliary Factor Homology Motif (UHM) Domains

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2023-03-214

OA

Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2022-10-013

OAAI

Graph-enhanced U-Net for semi-supervised segmentation of pancreas from abdomen CT scan

PHYSICS IN MEDICINE AND BIOLOGY

IF3.4

2022-07-2713

PRE

Core@Shell structured coal fly ash Magnetospheres@C/g-C3N4 for degradation of Rh B via photo-Fenton catalysis

JOURNAL OF ALLOYS AND COMPOUNDS

IF6.3

2022-07-0114

PRE

Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2022-01-1811

OA

Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors (vol 40, 116186, 2021)

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2022-01-010

OAAI

Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2021-06-017

PREAI

Resolution enhancement for lung 4D-CT based on transversal structures by using multiple Gaussian process regression learning

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS

IF2.7

2020-10-013

PREAI

Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-05-27155

PREAI